Arbutus Biopharma Corp ABUS:NASDAQ

Last Price$3.70Cboe Previous Close - Real-Time Last Sale as of 4:35PM ET 12/06/21
Cboe Real-Time Quotes
Today's Change0(0.00%)
Bid (Size)$4.07 (18)
Ask (Size)$4.08 (100)
Day Low / HighN/A - N/A
Volume1.9 M
 

View Biotechnology IndustryPeer Comparison as of 12/06/2021

 

Arbutus Biopharma Corp ( NASDAQ )

Price: $3.70
Change: -0.01 (0.27%)
Volume: 1.9 M
4:35PM ET 12/06/2021
 
 

Sierra Oncology Inc ( NASDAQ )

Price: $23.40
Change: +0.20 (0.86%)
Volume: 28.4 K
4:00PM ET 12/06/2021
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 
 

Neoleukin Therapeutics Inc ( NASDAQ )

Price: $5.40
Change: +0.19 (3.65%)
Volume: 256.0 K
4:00PM ET 12/06/2021
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 

Read more news Recent News

Insider Sell: Arbutus Biopharma
7:29AM ET 12/06/2021 MT Newswires

Michael J. Sofia, Chief Scientific Officer, on December 01, 2021, sold 200,000 shares in Arbutus Biopharma (ABUS) for $1,018,000. Following the Form 4...

Sector Update: Health Care Stocks Holding Up After Market Reversal Wednesday
4:02PM ET 12/01/2021 MT Newswires

Health care stocks escaped the brunt of Wednesday's late selloff, with the NYSE Health Care Index still rising 0.8% while the Health Care Select Sector...

Sector Update: Health Care
3:40PM ET 12/01/2021 MT Newswires

Health care stocks sidestepped a portion of Wednesday's late selloff, with the NYSE Health Care Index rising 0.8% while the SPDR Health Care Select Sector...

Arbutus Biopharma Shares Soar After Early Data Indicates Antiviral Activity For Chronic Hepatitis B Virus Treatment
2:54PM ET 12/01/2021 MT Newswires

Arbutus Biopharma (ABUS) shares surged intraday Wednesday after the company said an ongoing early-stage trial showed that its capsid inhibitor, AB-836,...

Company Profile

Business DescriptionArbutus Biopharma Corp. is a biopharmaceutical company. It engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA. View company web site for more details
Address701 Veterans Circle
Warminster, Pennsylvania 18974
Phone+1.267.469.0914
Number of Employees80
Recent SEC Filing12/03/20214
President, Chief Executive Officer & DirectorWilliam H. Collier
Chief Financial & Accounting OfficerDavid C. Hastings
Chief Scientific OfficerMichael J. Sofia
Secretary, Chief Compliance Officer & EVPElizabeth Howard

Company Highlights

Price Open$3.99
Previous Close$3.71
52 Week Range$2.43 - 6.50
Market Capitalization$500.5 M
Shares Outstanding135.3 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement03/03/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.90
Beta vs. S&P 500N/A
Revenue$5.9 M
Net Profit Margin-707.79%
Return on Equity-64.39%

Analyst Ratings as of 08/12/2021

Buy
3
Overweight
0
Hold
2
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset